C1739 HCPCS code: Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
C1739 is the HCPCS Level II code for tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 4 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | C codes — Outpatient PPS (hospital outpatient temporary codes) |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 53 |
| BETOS category | D1A — Medical/surgical supplies |
| Added | 2025-01-01 |
| Last action effective | 2025-10-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 4 | Code Descriptor / CPT Instruction |
| practitioner claims | 4 | Code Descriptor / CPT Instruction |
What changed for C1739
- October 2025: Descriptor revised (Was: Tissue marker, probe detectable any method (implantable), with delivery system)
- April 2025: Descriptor revised (Was: Tissue marker, imaging and non-imaging device (implantable))
- 2025-10-01: Last CMS action: long description changed
- 2025-01-01: C1739 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code C1739?
C1739 is the HCPCS Level II code for tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system. Short descriptor: "Marker uniq detect w/prbe".
Does Medicare cover C1739?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of C1739 can be billed per day?
4 on outpatient hospital claims; 4 on practitioner claims (NCCI medically unlikely edits).
Related C17 codes
- C1713 — Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)
- C1714 — Catheter, transluminal atherectomy, directional
- C1715 — Brachytherapy needle
- C1716 — Brachytherapy source, non-stranded, gold-198, per source
- C1717 — Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 — Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C1721 — Cardioverter-defibrillator, dual chamber (implantable)
- C1722 — Cardioverter-defibrillator, single chamber (implantable)
- C1724 — Catheter, transluminal atherectomy, rotational
- C1725 — Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)
- C1726 — Catheter, balloon dilatation, non-vascular
- C1727 — Catheter, balloon tissue dissector, non-vascular (insertable)
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under C1739
- Watch C1739 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for C1739
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.